Co-morbidity of drug addiction: An analysis of epidemiological data and possible etiological models

References

• Armstrong TD, Costello EJ. Community studies on adolescent substance use, abuse, or dependence and psychiatric comorbidity. Journal of Consulting and Clinical Psychology 2002; 70: 1224–1239
   PubMed Web of Science ®Google Scholar
• Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE. Cannabis use in adolescence and risk for adult psychosis: Longitudinal prospective study. British Medical Journal 2002; 325: 1212–1213
   PubMed Web of Science ®Google Scholar
• Barber JP, Frank A, Weiss R, Blaine J. Prevalence and correlates of personality disorder diagnoses among cocaine dependent outpatients. Journal of Personality Disorders 1996; 10: 297–311
   Web of Science ®Google Scholar
• Bizzarri JV, Sbrana A, Rucci P, Ravani L, Massei GJ, Gonnelli C, Spagnolli S, Doria MR, Raimondi F, Endicott J, et al. The spectrum of substance abuse in bipolar disorder: Reasons for use, sensation seeking and substance sensitivity. Bipolar Disorders 2007; 9: 213–220
   PubMed Web of Science ®Google Scholar
• Brooner RK, King VL, Kidorf M, Schmidt CW, Jr, Bigelow GE. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Archives of General Psychiatry 1997; 54: 71–80
   PubMed Web of Science ®Google Scholar
• Calsyn DA, Saxon AJ. Personality disorder subtypes among cocaine and opioid addicts using the millon clinical multiaxial inventory. International Journal of the Addictions 1990; 25: 1037–1049
   PubMed Web of Science ®Google Scholar
• Calsyn DA, Fleming C, Wells EA, Saxon AJ. Personality disorder subtypes among opiate addicts in methadone maintenance. Psychology of Addictive Behaviors 1996; 10: 3–8
   Web of Science ®Google Scholar
• Calsyn DA, Roszell DK, Chaney EF. Validation of MMPI profile subtypes among opioid addicts who are beginning methadone maintenance treatment. Journal of Clinical Psychology 1989; 45: 991–998
   PubMed Web of Science ®Google Scholar
• Chander G, McCaul ME. Co-occurring psychiatric disorders in women with addictions. Obstetrics and Gynecology Clinics of North America 2003; 30: 469–481
   PubMed Web of Science ®Google Scholar
• Cleary M, Hunt G, Matheson S, Siegfried N, Walter G. Psychosocial interventions programmes for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews 1 2008, CD001088
   Google Scholar
• Cohen A. The “urge to classify” the narcotic addict: A review of psychiatric classification. I. International Journal of Addictions 1982; 17: 213–225
   PubMed Web of Science ®Google Scholar
• Corkery JM, Baldacchino A. Definition and classification of comorbidity. Comorbidity: Perspectives across Europe, A Baldacchino, JM Corkery. European Collaborating Centres in Addiction Studies (ECCAS), London 2006; 3–43
   Google Scholar
• Craig RJ. Diagnostic interviewing with drug abusers. Professional Psychology: Research and Practice 1988a; 19: 14–20
   Google Scholar
• Craig RJ. A psychometric study of the prevalence of DSM-III personality disorders among treated opiate addicts. International Journal of Addictions 1988b; 23: 115–124
   PubMed Web of Science ®Google Scholar
• Craig RJ. Prevalence of personality disorders among cocaine and heroin addicts. Journal of Substance Abuse 2000; 21: 87–94
   Google Scholar
• Craig RJ, Olson RE. MCMI comparisons of cocaine abusers and heroin addicts. Journal of Clinical Psychology 1990; 46: 230–237
   PubMed Web of Science ®Google Scholar
• Craig RJ, Bivens A, Olson R. MCMI-III-derived typological analysis of cocaine and heroin addicts. Journal of Personality Assessment 1997; 69: 583–595
   PubMed Web of Science ®Google Scholar
• de Win MM, Reneman L, Reitsma JB, den Heeten GJ, Booij J, van den Brink W. Mood disorders and serotonin transporter density in ecstasy users–the influence of long-term abstention, dose, and gender. Psychopharmacology (Berl) 2004; 173: 376–382
   PubMed Web of Science ®Google Scholar
• Demetrovics Z. Family-history perspective of opiate addiction. Focusing on pre- and perinatal events. The International Journal of Prenatal and Perinatal Psychology and Medicine 2000; 12: 443–466
   Google Scholar
• Engstrom A, Adamsson C, Allebeck P, Rydberg U. Mortality in patients with substance abuse: A follow-up in Stockholm County, 1973–1984. International Journal of Addictions 1991; 26: 91–106
   PubMed Web of Science ®Google Scholar
• Falck RS, Wang J, Siegal HA, Carlson RG. The prevalence of psychiatric disorder among a community sample of crack cocaine users: An exploratory study with practical implications. Journal of Nervous and Mental Disease 2004; 192: 503–507
   PubMed Web of Science ®Google Scholar
• Flory K, Lynam DR. The relation between attention deficit hyperactivity disorder and substance abuse: What role does conduct disorder play?. Clinical Child and Family Psychology Review 2003; 6: 1–16
   PubMed Web of Science ®Google Scholar
• Goodwin RD, Fergusson DM, Horwood LJ. Association between anxiety disorders and substance use disorders among young persons: Results of a 21-year longitudinal study. Journal of Psychiatric Research 2004; 38: 295–304
   PubMed Web of Science ®Google Scholar
• Gouzoulis-Mayfrank E, Daumann J. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: How strong is the evidence for persistent brain damage?. Addiction 2006; 101: 348–361
   PubMed Web of Science ®Google Scholar
• Grilo CM, Becker DF, Walker ML, Levy KN, Edell WS, McGlashan TH. Psychiatric comorbidity in adolescent inpatients with substance use disorders. Journal of the American Academy of Child and Adolescent Psychiatry 1995; 34: 1085–1091
   PubMed Web of Science ®Google Scholar
• Henquet C, Krabbendam L, de Graaf R, Ten Have M, van Os J. Cannabis use and expression of mania in the general population. Journal of Affective Disorder 2006; 95: 103–110
   PubMed Web of Science ®Google Scholar
• Jacobsen LK, Southwick SM, Kosten TR. Substance use disorders in patients with posttraumatic stress disorder: A review of the literature. The American Journal of Psychiatry 2001; 158: 1184–1190
   PubMed Web of Science ®Google Scholar
• Johns A. Psychiatric effects of cannabis. British Journal of Psychiatry 2001; 178: 116–122
   PubMed Web of Science ®Google Scholar
• Kecskes I, Rihmer Z, Kiss K, Sarai T, Szabo A, Kiss GH. Gender differences in panic disorder symptoms and illicit drug use among young people in Hungary. European Psychiatry 2002; 17: 29–32
   PubMed Web of Science ®Google Scholar
• Kelly TM, Cornelius JR, Clark DB. Psychiatric disorders and attempted suicide among adolescents with substance use disorders. Drug Alcohol Dependence 2004; 73: 87–97
   PubMed Web of Science ®Google Scholar
• Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry 1994; 51: 8–19
   PubMed Web of Science ®Google Scholar
• Khantzian EJ, Treece C. DSM-III psychiatric diagnosis of narcotic addicts. Recent findings. Archives of General Psychiatry 1985; 42: 1067–1071
   PubMed Web of Science ®Google Scholar
• Khantzian EJ, Mack JE, Schatzberg AF. Heroin use as an attempt to cope: Clinical observations. American Journal of Psychiatry 1974; 131: 160–164
   PubMed Web of Science ®Google Scholar
• Kokkevi A, Stefanis C. Drug abuse and psychiatric comorbidity. Comprehensive Psychiatry 1995; 36: 329–337
   PubMed Web of Science ®Google Scholar
• Kosten TR, Markou A, Koob GF. Depression and stimulant dependence: neurobiology and pharmacotherapy. Journal of Nervous and Mental Disease 1998; 186: 737–745
   PubMed Web of Science ®Google Scholar
• Kosten TR, Rounsaville BJ, Kleber HD. DSM-III personality disorders in opiate addicts. Comprehensive Psychiatry 1982; 23: 572–581
   PubMed Web of Science ®Google Scholar
• Kranzler HR, Satel S, Apter A. Personality disorders and associated features in cocaine-dependent inpatients. Comprehensive Psychiatry 1994; 35: 335–340
   PubMed Web of Science ®Google Scholar
• Kreek MJ. Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine. Annals of the New York Academy of Sciences 2000; 909: 186–216
   PubMed Web of Science ®Google Scholar
• Maremmani I, Pani PP, Canoniero S, Pacini M, Perugi G, Rihmer Z, Akiskal HS. Is the bipolar spectrum the psychopathological substrate of suicidality in heroin addicts?. Psychopathology 2007; 40: 269–277
   PubMed Web of Science ®Google Scholar
• Moran P. Antisocial personality disorder. An epidemiological perspective. Gaskell, London 1999
   Google Scholar
• Myrick H, Brady K. Current review of the comorbidity of affective, anxiety, and substance use disorders. Current Opinion in Psychiatry 2003; 16: 261–270
   Web of Science ®Google Scholar
• Onken LS, Blaine JD, Genser S, Horton AM. Treatment of drug-dependent individuals with comorbid mental disorders. National Institute on Drug Abuse, Rockville 1997; 172
   Google Scholar
• Parrott AC. Human psychopharmacology of ecstasy (MDMA): A review of 15 years of empirical research. Human Psychopharmacology 2001; 16: 557–577
   PubMed Web of Science ®Google Scholar
• Patton GC, Coffey C, Carlin JB, Degenhardt L, Lynskey M, Hall W. Cannabis use and mental health in young people: Cohort study. British Medical Journal 2002; 325: 1195–1198
   PubMed Web of Science ®Google Scholar
• Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. Jama 1990; 264: 2511–2518
   PubMed Web of Science ®Google Scholar
• Regier DA, Rae DS, Narrow WE, Kaelber CT, Schatzberg AF. Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders. British Journal of Psychiatry 1998; 173: 24–28
   Web of Science ®Google Scholar
• Rey JM, Sawyer MG, Raphael B, Patton GC, Lynskey M. Mental health of teenagers who use cannabis. Results of an Australian survey. British Journal of Psychiatry 2002; 180: 216–221
   PubMed Web of Science ®Google Scholar
• Roberts A. Psychiatric comorbidity in white and African-American illicit substance abusers: Evidence for differential etiology. Clinical Psychology Review 2000; 20: 667–677
   PubMed Web of Science ®Google Scholar
• Room R. Alcohol and drug disorders in the international classification of diseases: A shifting kaleidoscope. Drug and Alcohol Review 1998; 17: 305–317
   PubMed Web of Science ®Google Scholar
• Rounsaville BJ, Kosten TR, Weissman MM, Kleber HD. Prognostic significance of psychopathology in treated opiate addicts. A 2.5-year follow-up study. Archives of General Psychiatry 1986; 43: 739–745
   PubMed Web of Science ®Google Scholar
• Rounsaville BJ, Weissman MM, Crits-Christoph K, Wilber C, Kleber H. Diagnosis and symptoms of depression in opiate addicts. Course and relationship to treatment outcome. Archives of General Psychiatry 1982a; 39: 151–156
   PubMed Web of Science ®Google Scholar
• Rounsaville BJ, Weissman MM, Kleber H, Wilber C. Heterogeneity of psychiatric diagnosis in treated opiate addicts. Archives of General Psychiatry 1982b; 39: 161–168
   PubMed Web of Science ®Google Scholar
• Rowe CL, Liddle HA, Greenbaum PE, Henderson CE. Impact of psychiatric comorbidity on treatment of adolescent drug abusers. Journal of Substance Abuse Treatment 2004; 26: 129–140
   PubMed Web of Science ®Google Scholar
• Sher KJ, Trull TJ. Substance use disorder and personality disorder. Current Psychiatry Reports 2002; 4: 25–29
   PubMedGoogle Scholar
• Sonne SC, Brady KT, Morton WA. Substance abuse and bipolar affective disorder. Journal of Nervous and Mental Disease 1994; 182: 349–352
   PubMed Web of Science ®Google Scholar
• Strain EC. Assessment and treatment of comorbid psychiatric disorders in opioid-dependent patients. Clinical Journal of Pain 2002; 18: S14–S27
   PubMed Web of Science ®Google Scholar
• Strakowski SM, DelBello MP. The co-occurrence of bipolar and substance use disorders. Clinical Psychology Review 2000; 20: 191–206
   PubMed Web of Science ®Google Scholar
• Sullivan MA, Rudnik-Levin F. Attention deficit/hyperactivity disorder and substance abuse. Diagnostic and therapeutic considerations. Annals of the New York Academy of Sciences 2001; 931: 251–270
   PubMed Web of Science ®Google Scholar
• Swendsen JD, Merikangas KR. The comorbidity of depression and substance use disorders. Clinical Psychology Review 2000; 20: 173–189
   PubMed Web of Science ®Google Scholar
• Tomlinson KL, Brown SA, Abrantes A. Psychiatric comorbidity and substance use treatment outcomes of adolescents. Psychology of Addictive Behaviors 2004; 18: 160–169
   PubMed Web of Science ®Google Scholar
• Torgersen S, Kringlen E, Cramer V. The prevalence of personality disorders in a community sample. Archives of General Psychiatry 2001; 58: 590–596
   PubMed Web of Science ®Google Scholar
• Torrens M, Serrano D, Astals M, Perez-Dominguez G, Martin-Santos R. Diagnosing comorbid psychiatric disorders in substance abusers: Validity of the Spanish versions of the psychiatric research interview for substance and mental disorders and the structured clinical interview for DSM-IV. American Journal of Psychiatry 2004; 161: 1231–1237
   PubMed Web of Science ®Google Scholar
• Trull TJ, Sher KJ, Minks-Brown C, Durbin J, Burr R. Borderline personality disorder and substance use disorders: A review and integration. Clinical Psychology Review 2000; 20: 235–253
   PubMed Web of Science ®Google Scholar
• van Os J, Bak M, Hanssen M, Bijl RV, de Graaf R, Verdoux H. Cannabis use and psychosis: A longitudinal population-based study. American Journal of Epidemiology 2002; 156: 319–327
   PubMed Web of Science ®Google Scholar
• Verheul R. Co-morbidity of personality disorders in individuals with substance use disorders. European Psychiatry 2001; 16: 274–282
   PubMed Web of Science ®Google Scholar
• Vornik LA, Brown ES. Management of comorbid bipolar disorder and substance abuse. Journal of Clinical Psychiatry 2006; 67: 24–30
   PubMed Web of Science ®Google Scholar
• Weaver T, Madden P, Charles V, Stimson G, Renton A, Tyrer P, Barnes T, Bench C, Middleton H, Wright N, et al. Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. British Journal of Psychiatry 2003; 183: 304–313
   PubMed Web of Science ®Google Scholar
• Weiss RD, Mirin SM. Subtypes of cocaine abusers. Psychiatric Clinics of North America 1986; 9: 491–501
   PubMed Web of Science ®Google Scholar
• Weiss RD, Kolodziej M, Griffin ML, Najavits LM, Jacobson LM, Greenfield SF. Substance use and perceived symptom improvement among patients with bipolar disorder and substance dependence. Journal of Affective Disorders 2004; 79: 279–283
   PubMed Web of Science ®Google Scholar
• Weiss RD, Mirin SM, Griffin ML, Gunderson JG, Hufford C. Personality disorders in cocaine dependence. Comprehensive Psychiatry 1993; 34: 145–149
   PubMed Web of Science ®Google Scholar
• Weiss RD, Najavits LM, Greenfield SF, Soto JA, Shaw SR, Wyner D. Validity of substance use self-reports in dually diagnosed outpatients. American Journal of Psychiatry 1998; 155: 127–128
   PubMed Web of Science ®Google Scholar
• Wurmser L. Psychoanalytic considerations of the etiology of compulsive drug use. Journal of the American Psychoanalytic Association 1974; 22: 820–843
   PubMed Web of Science ®Google Scholar
• Yates WR, Fulton AI, Gabel JM, Brass CT. Personality risk factors for cocaine abuse. American Journal of Public Health 1989; 79: 891–892
   PubMed Web of Science ®Google Scholar
• Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: Historical cohort study. British Medical Journal 2002; 325: 1199
   PubMed Web of Science ®Google Scholar
• Zimmerman M, Sheeran T, Chelminski I, Young D. Screening for psychiatric disorders in outpatients with DSM-IV substance use disorders. Journal of Substance Abuse Treatment 2004; 26: 181–188
   PubMed Web of Science ®Google Scholar